Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) (NCT07107841)
Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for the Treatment of Androgenic Alopecia (Single Site)
🩺 Plain-English Summary (8th-Grade Level)
(SINGLE SITE Study) The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365. Hair growth will be quantitatively measured for density and thickness. PROs will also be collected from participants. This study will be run at a SINGLE SITE.
Who can join: Review the eligibility criteria below.
Location: Ziering Medical — West Hollywood, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
- Autologous Hair Follicle-Derived Secretome (OTHER)
- Placebo Control (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Ziering Medical — West Hollywood, California
📞 Contact the Study Coordinator
Phone: (905) 695-6956
Email: lisa@acorn.me
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Androgenic Alopecia
- Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia — Maitland, Florida
- Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia — Winston-Salem, North Carolina
- A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth — Glenview, Illinois
- Computer-Assisted Hair Restoration Study Using ARTAS System — Los Altos, California
- Androgenic Alopecia TH07 Clinical Trial — Vancouver, British Columbia
Explore by condition: All Androgenic Alopecia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.